Author: Jaiswal, N; Bhatnagar, M; Shah, H
Title: N-acetycysteine: a potential therapeutic agent in COVID-19 infection Cord-id: e2za8pui Document date: 2020_7_24
ID: e2za8pui
Snippet: COVID-19 is an overwhelming pandemic which has shattered the whole world. Lung injury being the main clinical manifestation, it is likely to cause COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome). The possible cause behind this might be redox imbalance due to viral infection. Elevation in Glutathione (GSH) levels by administration of its promolecule might be effective. N-acetylcysteine is one such drug with potency to scavenge Reactive Oxygen Species, l
Document: COVID-19 is an overwhelming pandemic which has shattered the whole world. Lung injury being the main clinical manifestation, it is likely to cause COPD (chronic obstructive pulmonary disease) and ARDS (acute respiratory distress syndrome). The possible cause behind this might be redox imbalance due to viral infection. Elevation in Glutathione (GSH) levels by administration of its promolecule might be effective. N-acetylcysteine is one such drug with potency to scavenge Reactive Oxygen Species, least side effects, and an effective precursor of glutathione. Consequently we hypothesize that N-acetylcysteine along with the conventional treatment may be treated as a potential therapeutic solution in cases of COVID- 19 patients.
Search related documents:
Co phrase search for related documents- acetyl cysteine and lung injury: 1, 2, 3, 4
- activation innate immunity and acute ali lung injury: 1, 2, 3, 4
- activation innate immunity and lung injury: 1, 2, 3, 4, 5
- acute ali lung injury and lung inflammatory pathology: 1
- acute ali lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date